Efficacy and Safety of Three Different Cumulative Doses of Intravenous Methylprednisolone for Moderate to Severe and Active Graves' Orbitopathy | Zendy

Luigi Bartalena | Zendy; G. E. Krassas | Zendy; Wilmar M. Wiersinga | Zendy; Claudio Marcocci | Zendy; Mario Salvi | Zendy; Chantal Daumerie | Zendy; Claire Bournaud | Zendy; Matthias Stahl | Zendy; L. Sassi | Zendy; Giovanni Veronesi | Zendy; Claudio Azzolini | Zendy; Kostas Boboridis | Zendy; Maarten P. Mourits | Zendy; Maarten R. Soeters | Zendy; L. Baldeschi | Zendy; Marco Nardi | Zendy; Nicola Currò | Zendy; Antonella Boschi | Zendy; M. Bernard | Zendy; G. von Arx | Zendy

Open Access

Efficacy and Safety of Three Different Cumulative Doses of Intravenous Methylprednisolone for Moderate to Severe and Active Graves' Orbitopathy

Author(s) -

Luigi Bartalena,

G. E. Krassas,

Wilmar M. Wiersinga,

Claudio Marcocci,

Mario Salvi,

Chantal Daumerie,

Claire Bournaud,

Matthias Stahl,

L. Sassi,

Giovanni Veronesi,

Claudio Azzolini,

Kostas Boboridis,

Maarten P. Mourits,

Maarten R. Soeters,

L. Baldeschi,

Marco Nardi,

Nicola Currò,

Antonella Boschi,

M. Bernard,

G. von Arx

Publication year - 2012

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2012-2389

Subject(s) - medicine , adverse effect , methylprednisolone , diplopia , randomized controlled trial , exophthalmos , quality of life (healthcare) , statistical significance , regimen , palpebral fissure , cumulative dose , clinical trial , surgery , nursing

Optimal doses of i.v. glucocorticoids for Graves' orbitopathy (GO) are undefined.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research